Biotech · Public company · South San Francisco, CA, US
Alector, Inc.
Ticker ALEC · SEC CIK 0001653087
Track this companyFree. Adds Alector, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials121 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline11
- LatozinemabPhase 3 · Neurodegenerative DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- Part 1 Blinded - AL001Phase 3 · Frontotemporal DementiaClinicalTrials.gov · fetched Nov 12, 2026
- Part 2 (OLE Treatment) - AL001Phase 3 · Frontotemporal DementiaClinicalTrials.gov · fetched Nov 12, 2026
- AL001Phase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- AL001Phase 2 · Frontotemporal DementiaClinicalTrials.gov · fetched Nov 12, 2026
- AL002Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- AL002Phase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- AL001Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- AL002Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- AL003Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- AL101Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Open-label Extension Study in Participants With Early Alzheimer's DiseasePHASE2 · RECRUITING · started Aug 14, 2025ClinicalTrials.gov NCT07105709 · fetched Nov 12, 2026
- Continuation Study for LatozinemabPHASE3 · TERMINATED · started Dec 8, 2023ClinicalTrials.gov NCT06111014 · fetched Nov 12, 2026
- Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's DiseasePHASE2 · TERMINATED · started Oct 20, 2023ClinicalTrials.gov NCT06079190 · fetched Nov 12, 2026
- A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's DiseasePHASE2 · TERMINATED · started Jan 4, 2023ClinicalTrials.gov NCT05744401 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALSPHASE2 · TERMINATED · started Sep 2, 2021ClinicalTrials.gov NCT05053035 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's DiseasePHASE2 · COMPLETED · started Jan 22, 2021ClinicalTrials.gov NCT04592874 · fetched Nov 12, 2026
- A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)PHASE3 · TERMINATED · started Jul 23, 2020ClinicalTrials.gov NCT04374136 · fetched Nov 12, 2026
- A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101PHASE1 · COMPLETED · started Dec 14, 2019ClinicalTrials.gov NCT04111666 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)PHASE2 · COMPLETED · started Sep 27, 2019ClinicalTrials.gov NCT03987295 · fetched Nov 12, 2026
- First in Human Study for Safety and Tolerability of AL003.PHASE1 · COMPLETED · started Mar 29, 2019ClinicalTrials.gov NCT03822208 · fetched Nov 12, 2026
- A Phase I Study for Safety and Tolerability of AL002.PHASE1 · COMPLETED · started Nov 12, 2018ClinicalTrials.gov NCT03635047 · fetched Nov 12, 2026
- A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) MutationPHASE1 · COMPLETED · started Sep 14, 2018ClinicalTrials.gov NCT03636204 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 17, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026